Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today plans to invest more than $700 million ...

Roche's $1.25B investment in U.S. facilities boosts drug manufacturing and diabetes tech, creating thousands of jobs.

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North ...

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in Holly ...

Genentech, one of the world's premiere biotechnology companies headquartered in South San Francisco, California, announced it ...

Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...

Genentech, considered one of the biotech industry’s founding companies, plans to build a $700 million, 700,000-square-foot ...

The project could eventually add more than 400 manufacturing jobs and over 1,500 construction jobs during site development.

HOLLY SPRINGS, N.C. -- Genentech, a leading biotechnology company based in San Francisco, is set to build a $700 million ...

The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that ...

Genentech, a member of the Roche Group, will create 400 jobs with a new biotechnology facility in Holly Springs, Wake County, ...

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation obesity medicines.